IMMUNE GLOBULIN INTRAMUSCULAR
Drugs in Pregnancy and Lactation.
"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. |
Name: IMMUNE GLOBULIN INTRAMUSCULAR
Class: Serum
Risk Factor: CM
Fetal Risk Summary
Immune globulin IM (IGIM) is a solution of immunoglobulin, primarily immunoglobulin G, prepared from pooled plasma, that takes 2–5 days to obtain adequate serum levels (1). It is indicated for postexposure prophylaxis of hepatitis A and measles (rubeola), and in the prevention of serious infections in patients with immunoglobulin deficiencies. In cases of rubella exposure of the pregnant woman, IGIM, 0.55 mL/kg, administered as soon as possible after exposure may prevent or modify maternal infection, but there is no evidence that it will prevent fetal infection (2). However, its use in such cases may be of benefit in women who will not consider therapeutic abortion (2).
The American College of Obstetricians and Gynecologists Technical Bulletin No. 160 recommends the use of IGIM for postexposure prophylaxis of hepatitis A and measles (rubeola) (3). No risk to the fetus from this therapy has been reported (3).
Breast Feeding Summary
No data are available.
"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. |
References
- Product information. Gammar. Armour Pharmaceutical Co., 1993.
- American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 3rd Ed. Elk Grove Village, IL:American Academy of Pediatrics, and Washington, DC:American College of Obstetricians and Gynecologists, 1992:129.
- American College of Obstetricians and Gynecologists. Immunization during pregnancy. Technical Bulletin. No. 160, October 1991.
